Leprosy Mailing List – August 15, 2018
Ref.: (LML) Manifest Against the Implementation of U-MDT
From: Lisa Venida, Manila, Philippines
Dear all,
Thanks to Dr. Francesca Gajete for sending me the message of Dr. Robert Gelber, LML July 26, 2018.
I would encourage use of U-MDT for PB patients. In my clinical experience, we rarely use PB MDT, at JRRMMC Dermatology (Manila, Philippines), because only few of our patients falls under PB category. In the Philippines, PB cases are < 10% of all new patients and our PB MDT supplies are oftentimes not used up.
The beauty of MDT MB given to clinically PB Leprosy patients shows in one or two months the extent of clinical infection / affliction of our patients because of the darkened spots of the lesions on the skin area.
If SSS is done on clinically apparent lesions and turns out +, there is no more need to reclassify, just continue treatment for 12 months. If SSS is (-) on subsequent checking, then you just need to give treatment for 6 months and this brings comfort and alleviate patient fears of inappropriate treatment.
Lisa Venida
JRRMMC Dermatology
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
No comments:
Post a Comment